OJC: (2R,3R,3aS,5S,6R,7S,8R,11R,13S,15aR)-2-(6-amino-9H-purin-9-yl)-3,6,7,11,13-pentahydroxyoctahydro-2H,5H,11H,13H-5,8-epoxy-11lambda~5~,13lambda~5~-furo[2,3-g][1,3,5,9,2,4]tetraoxadiphosphacyclotetradecine-11,13-dione
OJC is a Ligand Of Interest in 8KBE designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 8KBE_OJC_B_201 | 73% | 51% | 0.14 | 0.969 | 0.74 | 1.13 | 2 | 3 | 0 | 0 | 100% | 1 |
| 8KBE_OJC_A_201 | 65% | 43% | 0.153 | 0.955 | 0.6 | 1.57 | - | 4 | 1 | 0 | 100% | 1 |
| 8SMD_OJC_B_201 | 83% | 31% | 0.109 | 0.969 | 1.44 | 1.33 | 7 | 5 | 0 | 0 | 100% | 1 |
| 8KBF_OJC_A_201 | 67% | 40% | 0.14 | 0.947 | 0.66 | 1.65 | - | 6 | 3 | 0 | 100% | 0.97 |
| 7UXS_OJC_A_501 | 99% | 63% | 0.06 | 0.988 | 0.6 | 0.8 | - | 1 | 0 | 0 | 100% | 1 |
| 8SMF_OJC_A_101 | 93% | 32% | 0.076 | 0.97 | 1.3 | 1.4 | 5 | 6 | 0 | 0 | 100% | 1 |
| 8KBL_OJC_A_201 | 43% | 48% | 0.219 | 0.943 | 0.8 | 1.2 | - | 5 | 0 | 0 | 100% | 0.5 |
